Logo image of CELH

CELSIUS HOLDINGS INC (CELH) Stock Fundamental Analysis

NASDAQ:CELH - US15118V2079 - Common Stock

61.26 USD
-1.62 (-2.58%)
Last: 9/2/2025, 10:19:08 AM
Fundamental Rating

5

Taking everything into account, CELH scores 5 out of 10 in our fundamental rating. CELH was compared to 33 industry peers in the Beverages industry. While CELH has a great health rating, there are worries on its profitability. CELH is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year CELH was profitable.
In the past year CELH had a positive cash flow from operations.
CELH had positive earnings in 4 of the past 5 years.
CELH had a positive operating cash flow in 4 of the past 5 years.
CELH Yearly Net Income VS EBIT VS OCF VS FCFCELH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

CELH has a worse Return On Assets (2.53%) than 60.61% of its industry peers.
CELH has a worse Return On Equity (4.59%) than 63.64% of its industry peers.
The Return On Invested Capital of CELH (4.58%) is worse than 72.73% of its industry peers.
Industry RankSector Rank
ROA 2.53%
ROE 4.59%
ROIC 4.58%
ROA(3y)0.55%
ROA(5y)1.88%
ROE(3y)0.83%
ROE(5y)2.49%
ROIC(3y)N/A
ROIC(5y)N/A
CELH Yearly ROA, ROE, ROICCELH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

Looking at the Profit Margin, with a value of 5.76%, CELH is in line with its industry, outperforming 45.45% of the companies in the same industry.
CELH's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 11.34%, CELH perfoms like the industry average, outperforming 48.48% of the companies in the same industry.
The Gross Margin of CELH (50.53%) is comparable to the rest of the industry.
CELH's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.34%
PM (TTM) 5.76%
GM 50.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y85.55%
PM growth 5Y-9.85%
GM growth 3Y7.15%
GM growth 5Y3.78%
CELH Yearly Profit, Operating, Gross MarginsCELH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

7

2. Health

2.1 Basic Checks

CELH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CELH has more shares outstanding than it did 1 year ago.
CELH has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CELH is higher compared to a year ago.
CELH Yearly Shares OutstandingCELH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CELH Yearly Total Debt VS Total AssetsCELH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

CELH has an Altman-Z score of 6.63. This indicates that CELH is financially healthy and has little risk of bankruptcy at the moment.
CELH's Altman-Z score of 6.63 is amongst the best of the industry. CELH outperforms 87.88% of its industry peers.
The Debt to FCF ratio of CELH is 4.14, which is a neutral value as it means it would take CELH, 4.14 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.14, CELH belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
A Debt/Equity ratio of 0.41 indicates that CELH is not too dependend on debt financing.
CELH has a better Debt to Equity ratio (0.41) than 63.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 4.14
Altman-Z 6.63
ROIC/WACC0.52
WACC8.87%
CELH Yearly LT Debt VS Equity VS FCFCELH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

CELH has a Current Ratio of 2.11. This indicates that CELH is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.11, CELH is doing good in the industry, outperforming 69.70% of the companies in the same industry.
CELH has a Quick Ratio of 1.76. This is a normal value and indicates that CELH is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CELH (1.76) is better than 87.88% of its industry peers.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 1.76
CELH Yearly Current Assets VS Current LiabilitesCELH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

8

3. Growth

3.1 Past

CELH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -46.89%.
Measured over the past years, CELH shows a very strong growth in Earnings Per Share. The EPS has been growing by 55.36% on average per year.
CELH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.85%.
Measured over the past years, CELH shows a very strong growth in Revenue. The Revenue has been growing by 78.36% on average per year.
EPS 1Y (TTM)-46.89%
EPS 3Y22.39%
EPS 5Y55.36%
EPS Q2Q%67.86%
Revenue 1Y (TTM)11.85%
Revenue growth 3Y62.78%
Revenue growth 5Y78.36%
Sales Q2Q%83.91%

3.2 Future

The Earnings Per Share is expected to grow by 40.00% on average over the next years. This is a very strong growth
Based on estimates for the next years, CELH will show a very strong growth in Revenue. The Revenue will grow by 21.17% on average per year.
EPS Next Y160.51%
EPS Next 2Y82.53%
EPS Next 3Y62.28%
EPS Next 5Y40%
Revenue Next Year74.44%
Revenue Next 2Y47.76%
Revenue Next 3Y34.78%
Revenue Next 5Y21.17%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CELH Yearly Revenue VS EstimatesCELH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B
CELH Yearly EPS VS EstimatesCELH Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 2 3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 113.44, CELH can be considered very expensive at the moment.
Based on the Price/Earnings ratio, CELH is valued a bit more expensive than the industry average as 63.64% of the companies are valued more cheaply.
CELH is valuated expensively when we compare the Price/Earnings ratio to 27.13, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 41.79, the valuation of CELH can be described as expensive.
CELH's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CELH is more expensive than 63.64% of the companies in the same industry.
CELH's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.76.
Industry RankSector Rank
PE 113.44
Fwd PE 41.79
CELH Price Earnings VS Forward Price EarningsCELH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CELH is valued a bit more expensive than 69.70% of the companies in the same industry.
CELH's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 74.95
EV/EBITDA 80.24
CELH Per share dataCELH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CELH's earnings are expected to grow with 62.28% in the coming years.
PEG (NY)0.71
PEG (5Y)2.05
EPS Next 2Y82.53%
EPS Next 3Y62.28%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CELH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CELSIUS HOLDINGS INC

NASDAQ:CELH (9/2/2025, 10:19:08 AM)

61.26

-1.62 (-2.58%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-04 2025-11-04/amc
Inst Owners58.37%
Inst Owner Change16.7%
Ins Owners18.51%
Ins Owner Change-2.23%
Market Cap15.80B
Analysts79.29
Price Target57.9 (-5.48%)
Short Float %12.45%
Short Ratio3.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP28.6%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)42.32%
Min EPS beat(2)-8.68%
Max EPS beat(2)93.31%
EPS beat(4)1
Avg EPS beat(4)-53.48%
Min EPS beat(4)-198.57%
Max EPS beat(4)93.31%
EPS beat(8)5
Avg EPS beat(8)-9.75%
EPS beat(12)7
Avg EPS beat(12)-35.34%
EPS beat(16)10
Avg EPS beat(16)4.08%
Revenue beat(2)1
Avg Revenue beat(2)2.54%
Min Revenue beat(2)-6.17%
Max Revenue beat(2)11.24%
Revenue beat(4)2
Avg Revenue beat(4)0.66%
Min Revenue beat(4)-6.17%
Max Revenue beat(4)11.24%
Revenue beat(8)5
Avg Revenue beat(8)0.37%
Revenue beat(12)8
Avg Revenue beat(12)3.87%
Revenue beat(16)12
Avg Revenue beat(16)6.11%
PT rev (1m)20.56%
PT rev (3m)33.09%
EPS NQ rev (1m)31.68%
EPS NQ rev (3m)14.02%
EPS NY rev (1m)43.35%
EPS NY rev (3m)24.43%
Revenue NQ rev (1m)6.63%
Revenue NQ rev (3m)39.53%
Revenue NY rev (1m)9.4%
Revenue NY rev (3m)10.4%
Valuation
Industry RankSector Rank
PE 113.44
Fwd PE 41.79
P/S 9.48
P/FCF 74.95
P/OCF 67.05
P/B 7.56
P/tB 235.97
EV/EBITDA 80.24
EPS(TTM)0.54
EY0.88%
EPS(NY)1.47
Fwd EY2.39%
FCF(TTM)0.82
FCFY1.33%
OCF(TTM)0.91
OCFY1.49%
SpS6.46
BVpS8.11
TBVpS0.26
PEG (NY)0.71
PEG (5Y)2.05
Profitability
Industry RankSector Rank
ROA 2.53%
ROE 4.59%
ROCE 6.03%
ROIC 4.58%
ROICexc 5.7%
ROICexgc 28.99%
OM 11.34%
PM (TTM) 5.76%
GM 50.53%
FCFM 12.65%
ROA(3y)0.55%
ROA(5y)1.88%
ROE(3y)0.83%
ROE(5y)2.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y85.55%
PM growth 5Y-9.85%
GM growth 3Y7.15%
GM growth 5Y3.78%
F-Score5
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 4.14
Debt/EBITDA 4.2
Cap/Depr 151.9%
Cap/Sales 1.49%
Interest Coverage 250
Cash Conversion 114.78%
Profit Quality 219.62%
Current Ratio 2.11
Quick Ratio 1.76
Altman-Z 6.63
F-Score5
WACC8.87%
ROIC/WACC0.52
Cap/Depr(3y)425.65%
Cap/Depr(5y)315.78%
Cap/Sales(3y)1.44%
Cap/Sales(5y)1.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-46.89%
EPS 3Y22.39%
EPS 5Y55.36%
EPS Q2Q%67.86%
EPS Next Y160.51%
EPS Next 2Y82.53%
EPS Next 3Y62.28%
EPS Next 5Y40%
Revenue 1Y (TTM)11.85%
Revenue growth 3Y62.78%
Revenue growth 5Y78.36%
Sales Q2Q%83.91%
Revenue Next Year74.44%
Revenue Next 2Y47.76%
Revenue Next 3Y34.78%
Revenue Next 5Y21.17%
EBIT growth 1Y-44.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year87.73%
EBIT Next 3Y45.91%
EBIT Next 5Y30.96%
FCF growth 1Y114.1%
FCF growth 3YN/A
FCF growth 5Y205.5%
OCF growth 1Y112.14%
OCF growth 3YN/A
OCF growth 5Y204.76%